These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37441486)

  • 1. Population Frequency of Undiagnosed Fabry Disease in the General Population.
    Kermond-Marino A; Weng A; Xi Zhang SK; Tran Z; Huang M; Savige J
    Kidney Int Rep; 2023 Jul; 8(7):1373-1379. PubMed ID: 37441486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis.
    Hannah WB; Seifert BA; Truty R; Zariwala MA; Ameel K; Zhao Y; Nykamp K; Gaston B
    Lancet Respir Med; 2022 May; 10(5):459-468. PubMed ID: 35051411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Prevalence of Deleterious
    LeDoux MS
    Tremor Other Hyperkinet Mov (N Y); 2020 Nov; 10():50. PubMed ID: 33200041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Fabry disease-causing variants in the UK Biobank.
    Gilchrist M; Casanova F; Tyrrell JS; Cannon S; Wood AR; Fife N; Young K; Oram RA; Weedon MN
    J Med Genet; 2023 Apr; 60(4):391-396. PubMed ID: 35977816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD).
    Kaler SG; Ferreira CR; Yam LS
    Mol Genet Metab Rep; 2020 Sep; 24():100602. PubMed ID: 32528851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a rare disease registry for establishing phenotypic classification of previously unassigned
    Germain DP; Oliveira JP; Bichet DG; Yoo HW; Hopkin RJ; Lemay R; Politei J; Wanner C; Wilcox WR; Warnock DG
    J Med Genet; 2020 Aug; 57(8):542-551. PubMed ID: 32161151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease.
    Dai X; Zong X; Pan X; Lu W; Jiang GR; Lin F
    Orphanet J Rare Dis; 2022 Jun; 17(1):237. PubMed ID: 35725559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
    Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
    J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study.
    Whitlock RH; Nour-Mohammadi M; Curtis S; Komenda P; Bohm C; Collister D; Tangri N; Rigatto C
    Can J Kidney Health Dis; 2023; 10():20543581231162218. PubMed ID: 36970566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Fabry disease in male patients with end-stage renal disease in western France.
    Vigneau C; Germain DP; Larmet D; Jabbour F; Hourmant M;
    Nephrol Ther; 2021 Jun; 17(3):180-184. PubMed ID: 33994139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort.
    Maruyama H; Taguchi A; Mikame M; Izawa A; Morito N; Izaki K; Seto T; Onishi A; Sugiyama H; Sakai N; Yamabe K; Yokoyama Y; Yamashita S; Satoh H; Toyoda S; Hosojima M; Ito Y; Tazawa R; Ishii S
    Curr Issues Mol Biol; 2021 Jun; 43(1):389-404. PubMed ID: 34205365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study.
    Russo C; Cocozza S; Riccio E; Pontillo G; Petruzzelli LA; Lanzillo R; Spinelli L; Colomba P; Duro G; Imbriaco M; Russo CV; De Riso G; Di Risi T; Tedeschi E; Cuocolo A; Brunetti A; Morra VB; Cocozza S; Pisani A
    J Neurol Sci; 2020 May; 412():116782. PubMed ID: 32234567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients.
    Doi K; Noiri E; Ishizu T; Negishi K; Suzuki Y; Hamasaki Y; Honda K; Fujita T; Tsukimura T; Togawa T; Saito S; Sakuraba H
    J Hum Genet; 2012 Sep; 57(9):575-9. PubMed ID: 22695894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants.
    Sánchez R; Ripoll-Vera T; López-Mendoza M; de Juan-Ribera J; Gimeno JR; Hermida Á; Ruz-Zafra MA; Torregrosa JV; Mora A; García-Pinilla JM; Fortuny E; Aguinaga-Barrilero A; Torra R
    Orphanet J Rare Dis; 2023 Jan; 18(1):8. PubMed ID: 36624527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients.
    Varela P; Mastroianni Kirsztajn G; Motta FL; Martin RP; Turaça LT; Ferrer HLF; Gomes CP; Nicolicht P; Mara Marins M; Pessoa JG; Braga MC; D'Almeida V; Martins AM; Pesquero JB
    Orphanet J Rare Dis; 2020 Jan; 15(1):30. PubMed ID: 31996269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence estimates of putatively pathogenic leptin variants in the gnomAD database.
    Rajcsanyi LS; Zheng Y; Fischer-Posovszky P; Wabitsch M; Hebebrand J; Hinney A
    PLoS One; 2022; 17(9):e0266642. PubMed ID: 36121795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease screening in high-risk populations in Japan: a nationwide study.
    Yoshida S; Kido J; Sawada T; Momosaki K; Sugawara K; Matsumoto S; Endo F; Nakamura K
    Orphanet J Rare Dis; 2020 Aug; 15(1):220. PubMed ID: 32843101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
    Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease.
    Germain DP; Levade T; Hachulla E; Knebelmann B; Lacombe D; Seguin VL; Nguyen K; Noël E; Rabès JP
    Clin Genet; 2022 Apr; 101(4):390-402. PubMed ID: 34927718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.